BFM
PDSB icon

Boothbay Fund Management’s PDS Biotechnology PDSB Stock Holding History

Boothbay Fund Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,507
Closed -$70.8K – 2182
2023
Q1 		$70.8K Buy
+11,507
New +$94.1K ﹤0.01% 1993
2021
Q2 		– Sell
-42,937
Closed -$195K – 2049
2021
Q1 		$195K Buy
+42,937
New +$173K 0.01% 1370
2019
Q1 		– Sell
-984
Closed -$6K – 848
2018
Q4 		$6K Hold
984
– – ﹤0.01% 627
2018
Q3 		$16K Buy
+984
New +$17.7K ﹤0.01% 763

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Boothbay Fund Management's PDSB Position: Q2 2023 in Review

Boothbay Fund Management sold out of PDS Biotechnology (PDSB) in Q2 2023, closing a stake of 11,507 shares — an estimated $70.8K sold.

Boothbay Fund Management first reported a position in PDSB in Q3 2018 and held it in 4 quarters. The position peaked at $195K in Q1 2021. 80 funds tracked by Wall St. Rank hold PDSB as of Q2 2023.

  • Boothbay Fund Management reported no remaining PDS Biotechnology position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 11,507 PDS Biotechnology shares in Q2 2023, an estimated $70.8K.
  • Boothbay Fund Management first reported a position in PDS Biotechnology in Q3 2018 and held it in 4 quarters.
  • Boothbay Fund Management's PDS Biotechnology position peaked at $195K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.